Mass General Brigham Innovation Fund Licensing Agreement with Biogen to Focus on Developing Treatment for Inherited Retinal Degeneration Due to Mutations in the PRPF31 Gene July, 2, 2020: (BOSTON) – Massachusetts Eye and Ear, a member…
Massachusetts Eye and Ear and Massachusetts General Hospital (MGH) today announced progress towards the testing and development of an experimental vaccine called AAVCOVID, a novel gene-based vaccine candidate against SARS-CoV2, the virus that causes COVID-19. The…
Medical research can be an electrifying experience as novel ideas are turned into life-altering solutions. On the other hand, research can also be incredibly frustrating, especially when your work has reached a desired result, yet, you’re not certain…
At the 2020 World Medical Innovation Forum, Joerg Moeller, MD, PhD reflected on how Bayer is weathering the organizational challenges posed by the COVID-19 pandemic. Moderated by Janet Wu of Bloomberg, this fireside chat covered possible…
Sorry, we couldn't find any posts. Please try a different search.
TOP 12 DISRUPTIVE HEALTHCARE TECHNOLOGIES Mapping spread of infectious diseases and reducing health disparities top list Mass General Brigham announced its selections for the sixth annual “Disruptive Dozen,” the 12 emerging clinical and artificial intelligence technologies…
Recent Posts by Category
Cardiovascular diseases remain the leading cause of death worldwide and rising expense, making this area ripe for AI-enabled innovations. This AI Update includes discussions…
TOP 12 DISRUPTIVE HEALTHCARE TECHNOLOGIES Mapping spread of infectious diseases and reducing health disparities top list Mass General Brigham announced its selections for the…
The Partners Innovation Fellows Program provides up-and-coming faculty/staff physicians and investigators from Partners with an opportunity to work with an industry partner on an…
Historically, scientists have thought of cancer cells as a clone army—since they are all genetically identical, they are universally bad actors. “What we’ve learned…
To read the full interview, click here.
Diseases related to thrombus and fibrosis are a key contributor to strokes, heart attacks, organ failure and death and result in billions of dollars…
The gap between the development of AI and its use and integration in the clinic is closing, as technology, sophisticated algorithms, data sets, and…
Mass General Brigham Innovation Fund Licensing Agreement with Biogen to Focus on Developing Treatment for Inherited Retinal Degeneration Due to Mutations in the PRPF31…
How do these new funds enhance the Partners Innovation Fund? These funds extend the capabilities we built with PIF. TIF will allow us to…
At the 2020 World Medical Innovation Forum, Joerg Moeller, MD, PhD reflected on how Bayer is weathering the organizational challenges posed by the COVID-19…
The 2020 Disruptive Dozen
TOP 12 DISRUPTIVE HEALTHCARE TECHNOLOGIES Mapping spread of infectious diseases and reducing health disparities top list Mass General Brigham announced its selections for the sixth annual “Disruptive Dozen,” the 12 emerging clinical and artificial intelligence technologies with the greatest potential to impact health care in the next year. The Disruptive…
Read MorePartners HealthCare Creates New Investment Funds to Accelerate Innovation in Medicine
$80M Investment to Speed Discovery from Lab to Patient, Fuel Life Sciences Economy Partners HealthCare has announced the creation of two new investment funds aimed at addressing the lack of translational funding in pre-clinical life sciences, Artificial Intelligence (AI) and digital technology development. The funds will support ventures that develop…
Read MoreNew “Staff Accelerator” Program Emphasizes Life-Long Learning and Commercialization Excellence
Developing people and keeping pace with the rapidly changing world of healthcare innovation is at the heart of a new “Staff Accelerator” (SA) pilot program just launched at Partners HealthCare Innovation. Combining mentoring programs, developmental opportunities and career and skills development workshops, the SA program is just one part of…
Read MorePfizer Centers for Therapeutic Innovation: Fall 2018 Call-for-Proposals due November 2nd 2018
We are pleased to alert you to the call for proposals for Pfizer’s Centers for Therapeutic Innovation (CTI) program for collaborative development of novel biotherapeutics. CTI supports translational programs in oncology, autoimmunity & inflammation, metabolic and rare diseases. Deadline to submit to Innovation: Friday, November 2nd 2018 How to apply: Please use…
Read More2019 Partners Innovation Discovery Grant Program: REQUEST FOR APPLICATIONS
We are delighted to announce the fourth round of the Innovation Discovery Grants Program (IDG). Partners HealthCare has renewed this grant program to stimulate new inventive concepts, identify areas of commercially significant scientific strength, and accelerate the creation of new products from the innovations of all Partners employees and faculty.…
Read MoreInnovators Honored at 2nd Annual Dinner
The Innovator’s Dinner was held Wednesday evening, April 25th as the concluding event of the 2018 World Medical Innovation Forum. This invitation-only dinner honored the 660 MGH, BWH, McLean and Spaulding principal investigators who submitted an invention disclosure during the calendar year 2017. Each investigator was recognized with a framed…
Read MorePrinted from https://innovationblog.partners.org/blog · Published 29 Jun 2020
© PARTNERS HEALTHCARE. ALL RIGHTS RESERVED
Subscribe
Never miss a post! Sign up to get new blog updates delivered to your email.
Connect